Boston, MA 05/30/2013 (wallstreetpr) – The share prices of Vermillion Inc. (NASDAQ:VRML) had surged by 10.09 percent to close at $3.71 per share for the end of last trading session. The share prices of the company had been recently increasing to new high levels with the recent adjustments in 52 week high price levels. The shares of Vermillion Inc. (NASDAQ:VRML) had been trading in the range of $3.45 to $3.95 per share during the day before closing at $0.34 per share higher over the previous day’s closing price.
Further, the shares of Vermillion Inc. (NASDAQ:VRML) had also recorded new 52 week high price levels at $3.95 per share and the 52 week low price level for the company is at $1.03 per share. The company’s shares had also experienced heavy trading volume of nearly 3 times the average level. Vermillion Inc. (NASDAQ:VRML) witnessed the exchange of 817,854 shares for the last trading session, while the average trading volume for the company is at 342,485 shares per day.
Vermillion Inc. (NASDAQ:VRML) is basically involved in enhancing the diagnostic solutions at clinics and hospitals so as to provide for better diagnostics of diseases by the doctors. The company is engaged in the research, development and commercialization of diagnostic tests which would help the physicians to better diagnose and treat their patients. The diagnostic tests of Vermillion Inc. (NASDAQ:VRML) are concentrated in the fields of oncology, cardiology and women’s health.
The company presently holds 15.20 million shares outstanding and the institutional ownership in Vermillion Inc. (NASDAQ:VRML) is at 11 percent of its holdings.
